CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

JPMorgan Adjusts Price Target on AbbVie to $280 From $260

Positive
AI Analysis

Summary

JPMorgan raised its price target on AbbVie from $260 to $280 per share.

Importance:2/10
Sentiment:
0.50
price_targetanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on July 9, 2026 3:29 PM

Read Original